epirubicin has been researched along with Germinoblastoma in 45 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 9 (20.00) | 18.7374 |
1990's | 16 (35.56) | 18.2507 |
2000's | 15 (33.33) | 29.6817 |
2010's | 5 (11.11) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kang, MH; Lee, YR; Park, HM | 1 |
Avilés, A | 1 |
Baldini, L; Barbolini, E; Brugiatelli, M; Dell'Olio, M; Dondi, A; Federico, M; Giglio, G; Gobbi, PG; Luminari, S; Mannina, D; Merli, F; Polimeno, G; Stelitano, C | 1 |
Chau, TN; Cheung, WI; Fung, KS; Lam, YK; Leung, VK; Lin, SY; Lo, FH | 1 |
Blackwood, L; Cripps, P; Elliott, JW; Grant, IA; Marrington, AM | 1 |
Brauchlin, A; Erne, P; Müller, A; Odermatt, Y; Toggweiler, S; Winterhalder, R; Zander, T; Zuber, M | 1 |
Alinari, L; Baccarani, M; Bonifazi, F; Gabriele, A; Molinari, AL; Salvucci, M; Stefoni, V; Tani, M; Tura, S; Zinzani, PL; Zuffa, E | 1 |
Apaja-Sarkkinen, M; Bode, MK; Johansson, J; Johansson, K; Kariniemi, J; Tikkakoski, T; Tuominen, H | 1 |
Gillett, M; Haak, S | 1 |
Chang, MC; Chao, TY; Chen, LT; Chen, PJ; Cheng, AL; Hsiung, CA; Hsu, CH; Kao, WY; Su, IJ; Tien, HF; Tsao, CJ; Uen, WC; Whang-Peng, J | 1 |
Hadjileontis, CG; Kaloutsi, VD; Kostopoulos, IS; Kotoula, VA; Nikolaou, AC; Papadimitriou, CS | 1 |
Berthou, C; Colombat, P; Deconinck, E; Delwail, V; Foussard, C; Gaillard, F; Gressin, R; Harousseau, JL; Lucas, V; Milpied, N | 1 |
Chen, TY; Huang, WT; Leaw, SJ; Su, WC; Tsao, CJ; Yen, CJ | 1 |
Baldinger, C; Fridrik, MA; Greil, R; Hausmaninger, H; Klocker, J; Krieger, O; Linkesch, W; Oberaigner, W; Pont, J | 1 |
Chang, MC; Chang, YF; Hsieh, RK; Huang, MJ; Lin, J; Su, YW | 1 |
Bishton, MJ; Fox, CP; Haynes, AP; McMillan, AK; Russell, NH | 1 |
Di Lauro, L; Lazzaro, B; Lopez, M; Papaldo, P | 1 |
Eridani, S; Pearson, TC; Singh, AK; Slater, NG | 1 |
Avilés, A; Delgado, S; Fernández, A; Nambo, MJ; Rosas, A | 1 |
Bettelheim, P; Kasparu, H; Kolb, A; Krieger, O; Lutz, D | 1 |
Bertini, M | 1 |
Denzlinger, C; Gerhartz, HH; Walther, J; Wilmanns, W | 1 |
Berdel, WE; Bron, DG; Cunningham, D; de Campos, E; De Greve, J; Howell, A; Seymour, AM; Steward, WP; Thatcher, N; Tueni, E | 1 |
Avilés, A; Delgado, S; Díaz-Maqueo, JC; García, EL; Guzmán, R; Nambo, MJ | 1 |
Keinànen, S; Laine, P; Lindqvist, C; Meurman, JH; Pyrhönen, S; Teerenhovi, L | 1 |
Anderson, S; Haynes, AP; McQuaker, IG; Russell, NH; Stainer, C | 1 |
Hatzl-Griesenhofer, M; Huber, H; Maschek, W; Pichler, R; Wahl, G; Wimmer, G | 1 |
Bauduer, F; Coiffier, B; Desablens, B | 1 |
Bang, YJ; Ha, SW; Huh, DS; Kim, IH; Park, CI; Wu, HG | 1 |
Heinz, R; Karlic, H; Mühlberger, H; Pavlova, B; Pfeilstöcker, M; Pittermann, E; Salamon, J; Strobl, H | 1 |
Chan, JK; Cheung, MM; So, JC; Wong, KF | 1 |
Angus, B; Carey, PJ; Conn, J; Culligan, D; Haynes, A; Iqbal, A; Jackson, GH; Lennard, AL; Leonard, RC; Lucraft, H; Proctor, SJ; Russel, N; Stark, A; Taylor, PR; Wood, K | 1 |
Browne, PV; Daly, PA; Duggan, C; Enright, H; Gardiner, N; Kennedy, MJ; McCann, SR; O'Connell, N | 1 |
Abdyldaev, RA; Bauér, IG; Dyĭkanbaeva, SK | 1 |
Gabizon, AA | 1 |
Allen, TM; Gabizon, A; Huang, SK; Lasic, DD; Lee, KD; Matthay, K; Mayhew, E; Papahadjopoulos, D; Redemann, C; Woodle, MC | 1 |
Ale, JJ; Comba, AZ; Garay, G; Gugliotta, HO; Milei, J; Otero, F; Storino, RA | 1 |
Eksborg, S | 1 |
Cersosimo, RJ; Hong, WK | 1 |
Barlow, AM; Sen, V | 1 |
Chiba, Y; Hirota, Y; Kobayashi, T; Masaoka, T; Sampi, K; Shibata, H; Shirakawa, S; Tamura, K; Toki, H; Yoshida, Y | 1 |
Furuta, I; Katayama, N; Kobayashi, T; Matsuoka, N; Ohno, T; Ohta, C; Shima, N; Shimizu, N; Tanaka, I; Uchida, T | 1 |
Boyd, MA; Case, DC; Ervin, TJ; Gams, R; Oldham, FB | 1 |
Dady, PJ; Lunt, H | 1 |
Di Lauro, L; Di Pietro, N; Ganzina, F; Lopez, M; Papaldo, P; Perno, CF | 1 |
1 review(s) available for epirubicin and Germinoblastoma
Article | Year |
---|---|
Epirubicin: a review of the pharmacology, clinical activity, and adverse effects of an adriamycin analogue.
Topics: Bone Marrow; Breast Neoplasms; Carcinoma, Renal Cell; Carcinoma, Small Cell; Colonic Neoplasms; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Epirubicin; Female; Head and Neck Neoplasms; Heart; Humans; Kidney Neoplasms; Kinetics; Leukemia; Liver Neoplasms; Lung Neoplasms; Lymphoma; Male; Melanoma; Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Rectal Neoplasms; Soft Tissue Neoplasms; Stomach Neoplasms; Urinary Bladder Neoplasms | 1986 |
13 trial(s) available for epirubicin and Germinoblastoma
Article | Year |
---|---|
Steroid-free chemotherapy decreases risk of hepatitis B virus (HBV) reactivation in HBV-carriers with lymphoma.
Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carrier State; Cyclophosphamide; Epirubicin; Etoposide; Female; Hepatitis B; Hepatitis B virus; Humans; Lymphoma; Male; Middle Aged; Prednisolone; Risk Factors; Survival Analysis; Treatment Outcome; Virus Activation | 2003 |
Initial treatment of aggressive lymphoma with high-dose chemotherapy and autologous stem-cell support.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Epirubicin; Female; Humans; Lymphoma; Male; Melphalan; Methotrexate; Middle Aged; Prednisone; Remission Induction; Stem Cell Transplantation; Survival Analysis; Transplantation, Autologous; Vincristine; Vindesine | 2004 |
Long-term results of dose density therapy in patients with aggressive lymphoma.
Topics: Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Cause of Death; Cyclophosphamide; Dexamethasone; Epirubicin; Etoposide; Humans; Ifosfamide; Longitudinal Studies; Lymphoma; Mesna; Methotrexate; Middle Aged; Prednisone; Survival Analysis; Treatment Failure; Treatment Outcome; Vincristine | 2005 |
A pilot study of epidoxorubicin (NSC 256942) in combination treatment of acute leukaemia and non-Hodgkin's lymphoma.
Topics: Acute Disease; Adult; Aged; Antibiotics, Antineoplastic; Clinical Trials as Topic; Doxorubicin; Epirubicin; Female; Humans; Leukemia; Lymphoma; Male; Middle Aged | 1984 |
Combined therapy for angioimmunoproliferative lesions.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Epirubicin; Female; Granuloma, Lethal Midline; Humans; Lymphoma; Male; Middle Aged; Prednisone; Prospective Studies; Vincristine | 1994 |
Therapeutic strategies in intermediate grade lymphomas in elderly patients. The Italian Multiregional non Hodgkin's Lymphoma Study Group (IMRNHLSG).
Topics: Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Epirubicin; Etoposide; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma; Prednisone; Recombinant Proteins; Survival Analysis; Time Factors; Vinblastine | 1993 |
Interleukin-3 enhances the endogenous leukotriene production.
Topics: Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Etoposide; Humans; Ifosfamide; Interleukin-3; Leukocyte Count; Leukotriene B4; Leukotrienes; Lymphoma; Recombinant Proteins | 1993 |
A single-blind, randomised, vehicle-controlled dose-finding study of recombinant human granulocyte colony-stimulating factor (lenograstim) in patients undergoing chemotherapy for solid cancers and lymphoma.
Topics: Adjuvants, Immunologic; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Epirubicin; Female; Granulocyte Colony-Stimulating Factor; Humans; Lenograstim; Leukocyte Count; Lymphoma; Male; Middle Aged; Neoplasms; Neutropenia; Recombinant Proteins; Single-Blind Method | 1995 |
Granisetron plus or minus alprazolam for emesis prevention in chemotherapy of lymphomas: a randomized multicenter trial. Granisetron Trialists Group.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alprazolam; Anti-Anxiety Agents; Antiemetics; Antineoplastic Agents; Cyclophosphamide; Dacarbazine; Doxorubicin; Epirubicin; Female; Granisetron; Humans; Lymphoma; Male; Middle Aged; Prednisone; Vomiting | 1999 |
Survival improvement with combined radio-chemotherapy in the primary central nervous system lymphomas.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Central Nervous System Neoplasms; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Epirubicin; Female; Humans; Lymphoma; Male; Mechlorethamine; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prednisolone; Procarbazine; Radiotherapy Dosage; Radiotherapy, Adjuvant; Survival Rate; Treatment Failure; Vincristine | 1999 |
High-dose ifosfamide in combination with etoposide and epirubicin (IVE) in the treatment of relapsed/refractory Hodgkin's disease and non-Hodgkin's lymphoma: a report on toxicity and efficacy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Etoposide; Female; Hodgkin Disease; Humans; Ifosfamide; Lymphoma; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Recurrence; Salvage Therapy; Survival Rate; Treatment Outcome | 2001 |
Effective progenitor cell mobilization in lymphoproliferative disorders using ifosfamide, epirubicin and etoposide (IEV).
Topics: Adolescent; Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Etoposide; Female; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Leukapheresis; Lymphoma; Lymphoproliferative Disorders; Male; Middle Aged; Salvage Therapy; Transplantation, Autologous; Treatment Outcome | 2001 |
[A trial of using farmorubicin in the therapy of malignant lymphomas].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Epirubicin; Female; Humans; Lymphoma; Male; Middle Aged; Remission Induction; Time Factors | 1992 |
31 other study(ies) available for epirubicin and Germinoblastoma
Article | Year |
---|---|
Anthracycline-induced cardiomyopathy in a dog treated with epirubicin.
Topics: Animals; Antibiotics, Antineoplastic; Cardiomyopathy, Dilated; Dog Diseases; Dogs; Epirubicin; Heart Failure; Lymphoma; Male | 2015 |
Breast lymphoma.
Topics: Antibiotics, Antineoplastic; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Breast Neoplasms; Clinical Trials, Phase II as Topic; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Epirubicin; Female; Humans; Immunologic Factors; Lymphoma; Middle Aged; Prednisone; Radiotherapy; Rituximab; Survival Analysis; Vincristine | 2008 |
Long term outcome of patients with localized aggressive non-Hodgkin lymphoma treated with PROMECE-CYTABOM plus involved-field radiation therapy: a study by the Gruppo Italiano Studio Linfomi.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Disease-Free Survival; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Multivariate Analysis; Prednisone; Radiotherapy; Retrospective Studies; Treatment Outcome; Vincristine | 2010 |
Prospective evaluation of seropositive occult hepatitis B viral infection in lymphoma patients receiving chemotherapy.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Carrier State; Cyclophosphamide; DNA, Viral; Epirubicin; Female; Guanine; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Liver Function Tests; Lymphoma; Male; Middle Aged; Prednisolone; Prospective Studies; Rituximab; Time Factors; Vincristine; Viral Load | 2011 |
Epirubicin as part of a multi-agent chemotherapy protocol for canine lymphoma.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Dog Diseases; Dogs; Epirubicin; Female; Lymphoma; Male; Retrospective Studies | 2013 |
The clinical value of echocardiography and acoustic cardiography to monitor patients undergoing anthracycline chemotherapy.
Topics: Age Factors; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antibiotics, Antineoplastic; Breast Neoplasms; Coronary Artery Disease; Doxorubicin; Echocardiography; Epirubicin; Female; Follow-Up Studies; Heart Sounds; Humans; Hypertension; Lymphoma; Male; Middle Aged; Multivariate Analysis; Phonocardiography; Prospective Studies; Sarcoma; Sensitivity and Specificity; Sex Factors; Stroke Volume; Systole; Ventricular Function, Left | 2013 |
Ifosfamide, epirubicin and etoposide regimen as salvage and mobilizing therapy for relapsed/refractory lymphoma patients.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Disease-Free Survival; Epirubicin; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Mobilization; Humans; Ifosfamide; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prognosis; Recurrence; Remission Induction; Salvage Therapy; Stem Cell Transplantation; Transplantation, Autologous; Treatment Outcome | 2002 |
[Diagnostics and therapy of cervical lymphoma].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Embolization, Therapeutic; Epirubicin; Female; Humans; Lymphoma; Middle Aged; Prednisolone; Uterine Cervical Neoplasms; Uterine Hemorrhage; Vincristine | 2003 |
Not just another fall in the elderly. Bilateral adrenal lymphoma presenting with adrenal insufficiency causing weakness.
Topics: Accidental Falls; Adrenal Gland Neoplasms; Adrenal Insufficiency; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Examination; Causality; Cyclophosphamide; Epirubicin; Family Practice; Humans; Hyponatremia; Immunophenotyping; Lymphoma; Male; Prednisone; Primary Health Care; Tomography, X-Ray Computed; Vincristine | 2003 |
An extremely rare case of synchronous occurrence in the larynx of intravascular lymphoma and in situ squamous cell carcinoma.
Topics: Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma in Situ; Carcinoma, Squamous Cell; Cyclophosphamide; Epirubicin; Humans; Immunohistochemistry; Laryngeal Neoplasms; Lymphoma; Male; Middle Aged; Prednisone; Time Factors; Treatment Outcome; Vascular Neoplasms; Vincristine | 2003 |
Preemptive use of interferon or lamivudine for hepatitis B reactivation in patients with aggressive lymphoma receiving chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Cyclophosphamide; Epirubicin; Female; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Interferon-alpha; Lamivudine; Lymphoma; Male; Middle Aged; Prednisone; Preventive Medicine; Retrospective Studies; Reverse Transcriptase Inhibitors; Secondary Prevention; Vincristine; Virus Activation | 2004 |
Clinical outcome of primary gastric lymphoma treated with chemotherapy alone or surgery followed by chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Epirubicin; Female; Humans; Lymphoma; Male; Middle Aged; Prednisone; Retrospective Studies; Stomach Neoplasms; Survival Rate; Taiwan; Vincristine | 2006 |
IVE (ifosfamide, epirubicin and etoposide) is a more effective stem cell mobilisation regimen than ICE (ifosphamide, carboplatin and etoposide) in the context of salvage therapy for lymphoma.
Topics: Adolescent; Adult; Aged; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Drug Evaluation; Epirubicin; Etoposide; Female; Hematopoietic Stem Cell Mobilization; Humans; Ifosfamide; Lymphoma; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Retrospective Studies; Salvage Therapy; Treatment Outcome | 2008 |
[Therapeutic activity of epirubicin in malignant melanoma and non-Hodgkin's lymphoma].
Topics: Adult; Aged; Antibiotics, Antineoplastic; Doxorubicin; Drug Evaluation; Epirubicin; Female; Humans; Lymphoma; Male; Melanoma; Middle Aged; Stereoisomerism | 1984 |
[Autologous stem cell harvesting after high dosage chemo- and/or growth factor therapy].
Topics: Adult; Blood Cell Count; Combined Modality Therapy; Cyclophosphamide; Cytapheresis; Epirubicin; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Lymphoma; Male; Middle Aged; Neoplasms; Remission Induction; Survival Rate; Transplantation, Autologous | 1995 |
Intensive brief chemotherapy with hematopoietic growth factors as hematological support and adjuvant radiotherapy improve the prognosis in aggressive malignant lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Epirubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Cell Growth Factors; Humans; Ifosfamide; Lymphoma; Male; Middle Aged; Prognosis; Remission Induction; Survival Rate | 1996 |
Five-year follow-up of saliva in patients treated for lymphomas.
Topics: Adult; Aged; Aged, 80 and over; Albumins; Amylases; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Dexamethasone; Doxorubicin; Epirubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Immunoglobulin A, Secretory; Leucovorin; Lymphoma; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Middle Aged; Muramidase; Prednisone; Procarbazine; Saliva; Salivary Proteins and Peptides; Secretory Rate; Statistics, Nonparametric; Vinblastine; Vincristine | 1997 |
Stem cell mobilization in resistant or relapsed lymphoma: superior yield of progenitor cells following a salvage regimen comprising ifosphamide, etoposide and epirubicin compared to intermediate-dose cyclophosphamide.
Topics: Adult; Aged; Cyclophosphamide; Drug Combinations; Epirubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Ifosfamide; Lymphoma; Male; Middle Aged; Multivariate Analysis; Transplantation Conditioning | 1997 |
[Primary lymphoma of the thyroid with contralateral recurrence--case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Citrates; Cyclophosphamide; Dexamethasone; Epirubicin; Etoposide; Female; Gallium; Gallium Radioisotopes; Humans; Ifosfamide; Lymphoma; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prednisolone; Radiopharmaceuticals; Remission Induction; Technetium; Thallium; Thyroid Neoplasms; Thyroidectomy; Vincristine | 1999 |
Hematopoietic recovery after IEV chemotherapy for malignant lymphoma followed by different cytokines can be monitored by analysis of Galpha 16 and CD34.
Topics: Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Cytokines; Epirubicin; Etoposide; Female; Gene Expression; GTP-Binding Protein alpha Subunits, Gq-G11; Hematopoiesis; Heterotrimeric GTP-Binding Proteins; Humans; Ifosfamide; Lymphoma; Male; Middle Aged; RNA, Messenger; Time Factors | 2000 |
Bone marrow involvement by nasal NK cell lymphoma at diagnosis is uncommon.
Topics: Adult; Aged; Aged, 80 and over; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Chemotherapy, Adjuvant; Cyclophosphamide; Cytarabine; Epirubicin; Etoposide; Female; Humans; Immunoenzyme Techniques; In Situ Hybridization; Killer Cells, Natural; Lymphoma; Male; Methotrexate; Middle Aged; Nose Neoplasms; Prednisone; Radiotherapy; RNA, Viral; Treatment Outcome; Vincristine | 2001 |
Selective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomes.
Topics: Animals; Doxorubicin; Drug Carriers; Epirubicin; Female; Liposomes; Liver; Lymphoma; Metabolic Clearance Rate; Mice; Mice, Inbred BALB C; Muscles; Myocardium; Phosphatidylcholines; Phosphatidylglycerols; Phosphatidylinositols; Tissue Distribution | 1992 |
Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy.
Topics: Animals; Colonic Neoplasms; Doxorubicin; Drug Carriers; Drug Stability; Epirubicin; Female; Gallium Radioisotopes; Liposomes; Lymphoma; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Tissue Distribution | 1991 |
Hemodynamic effects of chronic 4'epi-adriamycin administration.
Topics: Adult; Child; Electrocardiography; Epirubicin; Female; Hemodynamics; Humans; Lymphoma; Male; Middle Aged | 1990 |
Anthracycline pharmacokinetics. Limited sampling model for plasma level monitoring with special reference to epirubicin (Farmorubicin).
Topics: Adult; Aged; Doxorubicin; Epirubicin; Humans; Lymphoma; Middle Aged; Monitoring, Physiologic | 1990 |
Lymphoplasmacytoid lymphoma occurring in a patient with dermatitis herpetiformis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dermatitis Herpetiformis; Epirubicin; Humans; Lymphoma; Male; Prednisolone; Vincristine | 1988 |
[A phase II study of epirubicin in malignant lymphoma].
Topics: Adult; Aged; Anemia; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Epirubicin; Female; Humans; Leukopenia; Lymphoma; Male; Middle Aged | 1986 |
[Single-agent trial with epirubicin in hematological malignancies].
Topics: Acute Disease; Adult; Aged; Doxorubicin; Drug Evaluation; Epirubicin; Female; Humans; Leukemia; Lymphoma; Male; Middle Aged | 1987 |
Phase I-II trial of high-dose epirubicin in patients with lymphoma.
Topics: Adult; Aged; Alopecia; Antineoplastic Agents; Bone Marrow; Doxorubicin; Drug Evaluation; Epirubicin; Fever; Humans; Lymphoma; Middle Aged; Nausea; Stomatitis; Vomiting | 1987 |
Epirubicin, an effective new anticancer agent.
Topics: Antineoplastic Agents; Doxorubicin; Epirubicin; Humans; Lymphoma | 1985 |
Epirubicin in non-Hodgkin's lymphomas.
Topics: Adult; Aged; Alopecia; Doxorubicin; Epirubicin; Gastrointestinal Diseases; Humans; Leukopenia; Lymphoma; Middle Aged | 1985 |